Your session is about to expire
← Back to Search
Blood Collection Device
TAP20-C for Diabetes
N/A
Waitlist Available
Research Sponsored by Seventh Sense Biosystems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
Study Summary
This study will compare blood collection from the forearm using an investigational device TAP20-C to blood collection from the fingertip.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Non-Inferiority of Analyte Levels
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TAP20-CExperimental Treatment1 Intervention
TAP20-C
Group II: FingerstickActive Control1 Intervention
Fingerstick
Find a Location
Who is running the clinical trial?
Seventh Sense BiosystemsLead Sponsor
2 Previous Clinical Trials
2 Trials studying Diabetes
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger